Single pill could be used to treat Alzheimer's, Parkinson's and multiple sclerosis

 

A single pill has the potential to treat multiple brain conditions including Alzheimer's, Parkinson's and multiple sclerosis, it has been revealed.

Scientists have developed a new class of drug which can be taken orally and prevents the damaging effects of inflammation in the brain.

Early results from animal studies suggest it could be effective against a plethora of devastating brain conditions.

They include Alzheimer's and Parkinson's disease, multiple sclerosis (MS), motor neurone disease, frontotemporal dementia, and complications from traumatic brain injury.

Two of the drugs, known as MW151 and MW189, have been patented by US scientists at Northwestern University in Chicago.

They work by blocking excess production of damaging immune system signalling molecules called pro-inflammatory cytokines.

New research published in the Journal of Neuroscience showed how early treatment with MW151 prevented the development of full-blown Alzheimer's in laboratory mice.

Scientists say the drugs offer a completely different approach to treating the disease to others currently being tested.

These target the accumulation of beta amyloid protein deposits in the brain which are a key feature of Alzheimer's.

In contrast the new drugs are designed to stop inflammation disrupting wiring in the brain and killing neurons.

Pro-inflammatory cytokines cause the synapses, the connections between brain cells, to misfire. Eventually the whole organisation of the brain falls into disarray, like a failing computer, and neurons die.

"In Alzheimer's disease, many people now view the progression from mild cognitive impairment to full-blown Alzheimer's as an indication of malfunctioning synapses, the pathways that allow neurons to talk to each other," said Professor Martin Watterson, one of the study leaders at Northwestern University's Feinberg School.

"High levels of pro-inflammatory cytokines can contribute to synaptic malfunction."

Mice genetically engineered to develop Alzheimer's were given MW151 three times a week starting at six months of age. A comparable stage in humans would be when a patient begins to experience mild mental decline.

At 11 months, by which time the mice should have developed full-blown Alzheimer's, cytokine levels in the brains of the animals were found to be back to normal. Their synapses were also working normally.

Untreated mice had abnormally high brain levels of cytokines and their synapses were misfiring.

Co-author Dr Linda Van Eldik, director of the Sanders-Brown Centre on Aging at the University of Kentucky, said: "The drug protected against the damage associated with learning and memory impairment. Giving this drug before Alzheimer's memory changes are at a late stage may be a promising future approach to therapy."

Harmful inflammation also plays a role in a wide range of other neurodegenerative disorders, raising the prospect of using the drug to treat many different conditions.

Earlier tests on mice showed that MW151 reduced the severity of a disease similar to MS in humans that strips nerve fibres of their insulating myelin covering.

In other mouse experiments, the drug prevented a surge of pro-inflammatory cytokines after traumatic brain injury.

"If you took a drug like this early on after traumatic brain injury or even a stroke, you could possibly prevent the long-term complications of that injury including the risk of seizures, cognitive impairment, and, perhaps, mental health issues," said Professor Mark Wainright, also from Northwestern's Feinberg School.

Parkinson's, non-Alzheimer's dementia and motor neurone disease were other conditions that could potentially be tackled using the new approach.

A key advantage of the drug is that it can be swallowed as a pill, rather than being injected. It easily crosses the "blood brain barrier", a physical and molecular fortress wall that stops toxic molecules entering the brain.

Results are yet to be released from the first Phase I trial assessing the drug's safety in human patients.

This is the first step in winning clinical approval for a new treatment.

Dr Simon Ridley, head of research at the charity Alzheimer's Research UK, said: "This research takes an interesting approach to tackling Alzheimer's. Most current therapies in development target amyloid, whereas this drug appears to act by reducing the damage caused by activation of the immune system.

"We know that the immune system and inflammation are important players in Alzheimer's disease and so it's promising to see that this approach could hold benefits.

"These are early findings in mice and the drugs would need to be tested in humans before we could judge their true potential as a new treatment. With over half a million people in the UK living with Alzheimer's, effective new therapies are vital.

"Research is key to reaching this goal and we must keep investing in fresh ideas and new strategies if we are to tackle this devastating disease head-on."

PA

News
A 1930 image of the Karl Albrecht Spiritousen and Lebensmittel shop, Essen. The shop was opened by Karl and Theo Albrecht’s mother; the brothers later founded Aldi
people
Arts and Entertainment
Standing the test of time: Michael J Fox and Christopher Lloyd in 'Back to the Future'
filmA cult movie event aims to immerse audiences of 80,000 in ‘Back to the Future’. But has it lost its magic?
Arts and Entertainment
Flora Spencer-Longhurst as Lavinia, William Houston as Titus Andronicus and Dyfan Dwyfor as Lucius
theatreThe Shakespeare play that proved too much for more than 100 people
News
exclusivePunk icon Viv Albertine on Sid Vicious, complacent white men, and why free love led to rape
PROMOTED VIDEO
Life and Style
ebookA wonderful selection of salads, starters and mains featuring venison, grouse and other game
Arts and Entertainment
Stir crazy: Noel Fielding in 'Luxury Comedy 2: Tales from Painted Hawaii'
comedyAs ‘Luxury Comedy’ returns, Noel Fielding on why mainstream success scares him and what the future holds for 'The Boosh'
Life and Style
Flow chart: Karl Landsteiner discovered blood types in 1900, yet scientists have still not come up with an explanation for their existence
lifeAll of us have one. Yet even now, it’s a matter of debate what they’re for
Arts and Entertainment
'Weird Al' Yankovic, or Alfred Matthew, at the 2014 Los Angeles Film Festival Screening of
musicHis latest video is an ode to good grammar. But what do our experts think he’s missed out?
Sport
New Real Madrid signing James Rodríguez with club president Florentino Perez
sportColombian World Cup star completes £63m move to Spain
Travel
Hotel Tour d’Auvergne in Paris launches pay-what-you-want
travelIt seems fraught with financial risk, but the policy has its benefits
Arts and Entertainment
booksThe best children's books for this summer
Life and Style
News to me: family events were recorded in the personal columns
techFamily events used to be marked in the personal columns. But now Facebook has usurped that
Independent
Travel Shop
the manor
Up to 70% off luxury travel
on city breaks Find out more
santorini
Up to 70% off luxury travel
on chic beach resorts Find out more
sardina foodie
Up to 70% off luxury travel
on country retreats Find out more
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Sustainability Manager

    Competitive: The Green Recruitment Company: Job Title: Scheme Manager (BREEAM)...

    Graduate Sustainability Professional

    Flexible, depending on experience: The Green Recruitment Company: Job Title: T...

    Programme Director - Conduct Risk - London

    £850 - £950 per day: Orgtel: Programme Director - Conduct Risk - Banking - £85...

    Project Coordinator/Order Entry, SC Clear

    £100 - £110 per day: Orgtel: Project Coordinator/Order Entry Hampshire

    Day In a Page

    Noel Fielding's 'Luxury Comedy': A land of the outright bizarre

    Noel Fielding's 'Luxury Comedy'

    A land of the outright bizarre
    What are the worst 'Word Crimes'?

    What are the worst 'Word Crimes'?

    ‘Weird Al’ Yankovic's latest video is an ode to good grammar. But what do The Independent’s experts think he’s missed out?
    Can Secret Cinema sell 80,000 'Back to the Future' tickets?

    The worst kept secret in cinema

    A cult movie event aims to immerse audiences of 80,000 in ‘Back to the Future’. But has it lost its magic?
    Facebook: The new hatched, matched and dispatched

    The new hatched, matched and dispatched

    Family events used to be marked in the personal columns. But now Facebook has usurped the ‘Births, Deaths and Marriages’ announcements
    Why do we have blood types?

    Are you my type?

    All of us have one but probably never wondered why. Yet even now, a century after blood types were discovered, it’s a matter of debate what they’re for
    Honesty box hotels: You decide how much you pay

    Honesty box hotels

    Five hotels in Paris now allow guests to pay only what they think their stay was worth. It seems fraught with financial risk, but the honesty policy has its benefit
    Commonwealth Games 2014: Why weight of pressure rests easy on Michael Jamieson’s shoulders

    Michael Jamieson: Why weight of pressure rests easy on his shoulders

    The Scottish swimmer is ready for ‘the biggest race of my life’ at the Commonwealth Games
    Some are reformed drug addicts. Some are single mums. All are on benefits. But now these so-called 'scroungers’ are fighting back

    The 'scroungers’ fight back

    The welfare claimants battling to alter stereotypes
    Amazing video shows Nasa 'flame extinguishment experiment' in action

    Fireballs in space

    Amazing video shows Nasa's 'flame extinguishment experiment' in action
    A Bible for billionaires

    A Bible for billionaires

    Find out why America's richest men are reading John Brookes
    Paranoid parenting is on the rise - and our children are suffering because of it

    Paranoid parenting is on the rise

    And our children are suffering because of it
    For sale: Island where the Magna Carta was sealed

    Magna Carta Island goes on sale

    Yours for a cool £4m
    Phone hacking scandal special report: The slide into crime at the 'News of the World'

    The hacker's tale: the slide into crime at the 'News of the World'

    Glenn Mulcaire was jailed for six months for intercepting phone messages. James Hanning tells his story in a new book. This is an extract
    We flinch, but there are degrees of paedophilia

    We flinch, but there are degrees of paedophilia

    Child abusers are not all the same, yet the idea of treating them differently in relation to the severity of their crimes has somehow become controversial
    The truth about conspiracy theories is that some require considering

    The truth about conspiracy theories is that some require considering

    For instance, did Isis kill the Israeli teenagers to trigger a war, asks Patrick Cockburn